CYCLOPHARM LIMITED — Capital/Financing Update 2012

Dec 10, 2012

==> picture [167 x 59] intentionally omitted <==

Tuesday 11 December 2012

cyclo medica molecular imaging techne gas Cyclopharm Ltd ABN 74 116 931 250 Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW 2234 Australia POB 350 Menai Central NSW 2234 T 61 2 9541 0411 F 61 2 9543 0960 www.cyclopharm.com.au

Completion of Rights Issue and notice of under subscriptions

Cyclopharm Limited ( Company ) today announced the completion of the renounceable prorata entitlement offer ( Rights Issue ) announced on 9 November 2012.

The Company received acceptances to raise $1,290,035.02 at $0.18 per share. The Rights Issue was undersubscribed by 4,458,945 shares. The shortfall will be taken up by the Underwriter under the underwriting agreement.

For further information please contact the Company.

==> picture [109 x 29] intentionally omitted <==

James McBrayer Managing Director

legal/40704726_1